Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Guanqiao Li

Has grant

Assistant Professor / Special Research Fellow

Tsinghua University

China

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Recent Grants

Grant: Open

Research on Efficacy Prediction and Decision Support for Tumor Drug Combination Therapy Based on Deep Learning and Tumor-Immune-Stroma Biological Models

Open Date: 2024-01-01

Close Date: 2027-01-01

Grant: Close

Research on Clinical Efficacy Prediction and Decision Support for Anti-Tumor Combination Therapy Based on Tumor Biological Models and Deep Learning

Open Date: 2023-01-01

Close Date: 2026-01-01

Articles (11)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (3)

Nan Jiang

Associate Professor

Tsinghua University

CHINA

View details

Nancy A. Dreyer

University of North Carolina at Chapel Hill

UNITED STATES

View details

Ariadna Tibau Martorell

Brigham and Women's Hospital

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Guanqiao Li

Research Interests

Make your next move.

Recent Grants

Articles (11)

Risk of bias and clinical benefit of phase III trials supporting FDA-approved anticancer medicines, 2018–2025: A cross-sectional analysis

The evolving global landscape of first-in-class oncology drug innovation

Therapeutic value and regulatory characteristics of breakthrough therapy drugs in the USA and China (2021–2023): a retrospective cohort study

Potential causal effect of SLE on osteoporosis, and the mediation effect: a Mendelian randomisation study

Health-Related Quality of Life, Psychological Health, and Patient-Reported Outcomes of Amyotrophic Lateral Sclerosis Patients in China

Digital Therapeutics in China: Comprehensive Review

Regulatory flexibilities balancing unmet needs, benefits and risks in the approvals of imported cancer drugs in China: a cohort study from 2012 to 2021

Accelerated approvals: Early-phase success or premature authorization?

Chinese innovative drug R&D trends in 2024

Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors

The R&D landscape for infectious disease vaccines

Collaborators (3)

Nan Jiang

Nancy A. Dreyer

Ariadna Tibau Martorell

Make your next move.